(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Picking the Right Doctor prescribed Medication Inclusion in Senior Protection. - 2Liste des pr\u00eats qui ne n\u00e9cessitent pas de remboursement
- 3New study measures titanium in Apollo rock to uncover Moon’s early chemistry
- 4Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
- 5Picking the Right Air Purifier for Your Home
- New science points to 4 distinct types of autism
- What Yogurt Types Do You Know
- Russian drone slams into block of flats in deadly wave of strikes across Kyiv
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
- FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- Vote in favor of the juice that you love for its medical advantages!
- Honda’s Biggest Flex Isn’t Its Superbikes, It’s Selling 500K Bikes In One Month
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- These Cities Led Global Jet-Setting In 2025, According To New Data
